本页面由Tiger Trade Technology Pte. Ltd.提供服务

Akero Therapeutics

54.65
0.0000
成交量:- -
成交额:8.36亿
市值:44.99亿
市盈率:-14.61
高:54.65
开:54.65
低:54.65
收:54.65
52周最高:58.40
52周最低:21.34
股本:8,232.44万
流通股本:6,777.24万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-3.7418
每股收益(LYR):-3.7544
净资产收益率:-34.53%
总资产收益率:-22.63%
市净率:4.70
市盈率(LYR):-14.56

数据加载中...

2023/06/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/05

重要事件披露

Form 8-K - Current report
2023/05/17

重要事件披露

Form 8-K - Current report
2023/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/15

重要事件披露

Form 8-K - Current report
2023/04/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/04/03

关联方拟减持公告

144 - Report of proposed sale of securities
2023/03/29

重要事件披露

8-K - Current report
2023/03/17

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/17

重要事件披露

8-K - Current report
2023/03/17

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/17

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals